Hongfen Lu

1.2k total citations
45 papers, 930 citations indexed

About

Hongfen Lu is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Hongfen Lu has authored 45 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 22 papers in Pathology and Forensic Medicine and 15 papers in Cancer Research. Recurrent topics in Hongfen Lu's work include Breast Cancer Treatment Studies (11 papers), Lymphoma Diagnosis and Treatment (11 papers) and Viral-associated cancers and disorders (8 papers). Hongfen Lu is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), Lymphoma Diagnosis and Treatment (11 papers) and Viral-associated cancers and disorders (8 papers). Hongfen Lu collaborates with scholars based in China, United States and Singapore. Hongfen Lu's co-authors include Wentao Yang, Daren Shi, Yufan Cheng, Weiqi Sheng, Yanong Wang, Xiaowen Liu, Huiyan Zhu, Ye Guo, Xiaoyu Tu and Biyun Wang and has published in prestigious journals such as Cancer Research, The American Journal of Surgical Pathology and Journal of Clinical Pathology.

In The Last Decade

Hongfen Lu

45 papers receiving 907 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongfen Lu China 18 414 327 229 202 201 45 930
Sandra J. Shin United States 15 400 1.0× 266 0.8× 236 1.0× 78 0.4× 223 1.1× 26 802
Nurija Bilalović Bosnia and Herzegovina 14 333 0.8× 239 0.7× 112 0.5× 106 0.5× 147 0.7× 45 701
Pier Selenica United States 21 424 1.0× 274 0.8× 194 0.8× 324 1.6× 393 2.0× 77 1.2k
Siu‐Ki Chan China 20 565 1.4× 206 0.6× 138 0.6× 248 1.2× 298 1.5× 43 1.1k
Amir Behdad United States 22 543 1.3× 303 0.9× 216 0.9× 292 1.4× 451 2.2× 93 1.3k
Lúcia Roque Portugal 24 562 1.4× 296 0.9× 323 1.4× 153 0.8× 199 1.0× 49 1.5k
Bolette L. Caron United States 11 341 0.8× 225 0.7× 91 0.4× 317 1.6× 141 0.7× 12 843
Beth Z. Clark United States 17 332 0.8× 292 0.9× 120 0.5× 174 0.9× 307 1.5× 47 782
Paul Fréneaux France 13 333 0.8× 359 1.1× 97 0.4× 257 1.3× 261 1.3× 27 912
Sıtkı Tuzlalı Türkiye 16 312 0.8× 297 0.9× 187 0.8× 138 0.7× 370 1.8× 50 836

Countries citing papers authored by Hongfen Lu

Since Specialization
Citations

This map shows the geographic impact of Hongfen Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongfen Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongfen Lu more than expected).

Fields of papers citing papers by Hongfen Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongfen Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongfen Lu. The network helps show where Hongfen Lu may publish in the future.

Co-authorship network of co-authors of Hongfen Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Hongfen Lu. A scholar is included among the top collaborators of Hongfen Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongfen Lu. Hongfen Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bai, Qianming, Ming Li, Shuling Zhou, et al.. (2024). Response to anti-HER2 neoadjuvant chemotherapy in HER2-positive invasive breast cancers with different HER2 FISH patterns. Journal of Clinical Pathology. 78(8). 540–547. 3 indexed citations
2.
Zhou, Shuling, Hong Lv, Xiaochun Wan, et al.. (2023). FOXC1 and SOX10 in Estrogen Receptor–Low Positive/HER2-Negative Breast Cancer: Potential Biomarkers for the Basal-like Phenotype Prediction. Archives of Pathology & Laboratory Medicine. 148(4). 461–470. 3 indexed citations
3.
Lv, Hong, et al.. (2021). FOXC1. Archives of Pathology & Laboratory Medicine. 146(8). 994–1003. 13 indexed citations
4.
Tu, Xiaoyu, Hongfen Lu, Ruohong Shui, et al.. (2019). [Invasive breast lobular carcinoma with extracellular mucin: a clinicopathological analysis].. PubMed. 48(10). 779–783. 1 indexed citations
5.
Zhu, Xiaoli, Yongming Lu, Hongfen Lu, et al.. (2011). Genetic alterations and protein expression of HER2 and chromosome 17 polysomy in breast cancer. Human Pathology. 42(10). 1499–1504. 11 indexed citations
6.
Li, Dali, Xiuying Xiao, Wentao Yang, et al.. (2011). Secretory breast carcinoma: a clinicopathological and immunophenotypic study of 15 cases with a review of the literature. Modern Pathology. 25(4). 567–575. 71 indexed citations
7.
Chen, Xiaosong, Jiayi Wu, Hongfen Lu, Ou Huang, & Kunwei Shen. (2011). Measuring β‐tubulin III, Bcl‐2, and ERCC1 improves pathological complete remission predictive accuracy in breast cancer. Cancer Science. 103(2). 262–268. 23 indexed citations
8.
Zhu, Xiaoli, Tuanqi Sun, Hongfen Lu, et al.. (2010). Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinoma. Journal of Clinical Pathology. 63(9). 786–789. 39 indexed citations
9.
Liu, Xiaowen, Yufan Cheng, Weiqi Sheng, et al.. (2010). Clinicopathologic features and prognostic factors in alpha‐fetoprotein‐producing gastric cancers: Analysis of 104 cases. Journal of Surgical Oncology. 102(3). 249–255. 135 indexed citations
10.
Liu, Xiaowen, Yufan Cheng, Weiqi Sheng, et al.. (2010). Analysis of Clinicopathologic Features and Prognostic Factors in Hepatoid Adenocarcinoma of the Stomach. The American Journal of Surgical Pathology. 34(10). 1465–1471. 71 indexed citations
11.
Kong, Yunyi, Bo Dai, Jincheng Kong, Hongfen Lu, & Daren Shi. (2009). Neutrophil/eosinophil‐rich type of primary cutaneous anaplastic large cell lymphoma: a clinicopathological, immunophenotypic and molecular study of nine cases. Histopathology. 55(2). 189–196. 21 indexed citations
12.
13.
Wang, Biyun, et al.. (2008). Immunohistochemical expression and clinical significance of P‐glycoprotein in previously untreated extranodal NK/T‐cell lymphoma, nasal type. American Journal of Hematology. 83(10). 795–799. 83 indexed citations
14.
Huang, Wentao, Xiaoqiu Li, Xiaohong Yao, et al.. (2008). Expression of ALK protein, mRNA and fusion transcripts in anaplastic large cell lymphoma. Experimental and Molecular Pathology. 86(2). 121–126. 3 indexed citations
15.
Cai, Guoxiang, Ye Xu, Hongfen Lu, et al.. (2008). Clinicopathologic and molecular features of sporadic microsatellite- and chromosomal-stable colorectal cancers. International Journal of Colorectal Disease. 23(4). 365–373. 17 indexed citations
16.
Xu, Xun, Fenghua Wang, Xi Zhang, et al.. (2007). Effects of Nerve Growth Factor for Retinal Cell Survival in Experimental Retinal Detachment. Current Eye Research. 32(9). 765–772. 27 indexed citations
17.
Kong, Yun-Yi, Hongfen Lu, Xiongzeng Zhu, et al.. (2005). [Cutaneous Rosai-Dorfman disease].. PubMed. 34(3). 133–6. 4 indexed citations
18.
Wang, Lu, Zhao–You Tang, Hui‐Chuan Sun, et al.. (2001). Nitric oxide synthase and vascular endothelial growth factor expression in hepatocellular carcinoma and the correlation with angiogenesis. Chinese Journal of Cancer Research. 13(2). 124–127. 2 indexed citations
19.
Cai, Qi, et al.. (2000). Expression of two CD44 variant proteins (v3 and v6) in human colorectal carcinoma and its relevance for prognosis. World Journal of Gastroenterology. 6. 128–128. 1 indexed citations
20.
Yao, Min, Xin‐Da Zhou, Xiliang Zha, et al.. (1997). Expression of the integrin? 5 subunit and its mediated cell adhesion in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 123(8). 435–440. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandra J. Shin Breakdown of academic impact, for papers by Nurija Bilalović Breakdown of academic impact, for papers by Pier Selenica Breakdown of academic impact, for papers by Siu‐Ki Chan Breakdown of academic impact, for papers by Amir Behdad Breakdown of academic impact, for papers by Lúcia Roque Breakdown of academic impact, for papers by Bolette L. Caron Breakdown of academic impact, for papers by Beth Z. Clark Breakdown of academic impact, for papers by Paul Fréneaux Breakdown of academic impact, for papers by Sıtkı Tuzlalı
Rankless by CCL
2026